MedTrace Logo

Effect of Zinc and Selenium Supplementation on HIV+ Individuals on Antiretroviral Treatment.

NCT03421314 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2019-01-30

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of zinc gluconate and/or selenium yeast supplementation during six months on clinical (glucose, cholesterol, triglycerides, bone mineral density and body composition) and immunological (oxidative stress, CD4+ count and pro-inflammatory cytokines) parameters in a population with HIV diagnosis on antiretroviral treatment.

Conditions

  • HIV
  • ART
  • Zinc Deficiency
  • Selenium Deficiency
  • Metabolic Complication
  • Inflammation

Interventions

DIETARY_SUPPLEMENT

Zinc gluconate and/or Selenium yeast

30 mg dose of zinc gluconate and/or 200 mcg of selenium yeast

Sponsors & Collaborators

  • Instituto Nacional de Enfermedades Respiratorias

    lead OTHER_GOV

Principal Investigators

  • Gustavo Reyes Teran, MD · Principal investgator

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2019-12-31
Completion
2020-01-01

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03421314 on ClinicalTrials.gov